Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
06/14/2001 | WO2001042437A2 Histone deacetylase-8 proteins, nucleic acids, and methods of use |
06/14/2001 | WO2001042434A1 Dna molecules encoding human nhl, a dna helicase |
06/14/2001 | WO2001042429A1 Infection of eukaryotic cells with viruses in vitro |
06/14/2001 | WO2001042428A1 Method for production of a skin graft and the graft produced thereby |
06/14/2001 | WO2001042425A2 Lung stem cells and lung regeneration |
06/14/2001 | WO2001042423A2 Compositions and methods for detecting stress-inducible proteins |
06/14/2001 | WO2001042421A2 Long-term cell culture compositions and genetically modified animals derived therefrom |
06/14/2001 | WO2001042307A1 MUTANT ERα AND TEST SYSTEMS FOR TRANSACTIVATION |
06/14/2001 | WO2001042305A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
06/14/2001 | WO2001042301A1 Interferon-alpha induced gene |
06/14/2001 | WO2001042300A1 Process for producing functional silk fibroin and utilization of the same |
06/14/2001 | WO2001042288A2 G-protein coupled receptors |
06/14/2001 | WO2001042270A1 Inducing cellular immune responses to carcinoembryonic antigen using peptide and nucleic acid compositions |
06/14/2001 | WO2001042211A2 Detection of transmembrane potentials by optical methods |
06/14/2001 | WO2001041809A1 Application of polyacrylamide gel for forming a capsule in the tissue of a mammal organism, method for cultivating cells and method for therapy of oncological diseases and the diabetes mellitus |
06/14/2001 | WO2001041799A1 Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions |
06/14/2001 | WO2001041792A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
06/14/2001 | WO2001041791A1 Contortrostatin (cn) and methods for its use in preventing metastasis and other conditions |
06/14/2001 | WO2001041787A1 INDUCING CELLULAR IMMUNE RESPONSES TO HER2/neu USING PEPTIDE AND NUCLEIC ACID COMPOSITIONS |
06/14/2001 | WO2001041759A1 Methods for modulation of oocyte activation |
06/14/2001 | WO2001027244A9 Body member with adjustable stiffness and frequency |
06/14/2001 | WO2001025253A3 Temperature-sensitive regulation of viral vector production |
06/14/2001 | WO2001012826A3 Nucleic acid molecules derived from plants which code for enzymes which are involved in the synthesis of starch |
06/14/2001 | WO2001009189A3 Compositions and methods for the treatment of tumors |
06/14/2001 | WO2001000829A8 Human endogenous retrovirus in breast cancer |
06/14/2001 | WO2001000812A3 22012, a novel human carboxypeptidase |
06/14/2001 | WO2000035950A9 Reagents and methods useful for detecting diseases of the breast |
06/14/2001 | US20010003650 Fusion proteins capapble of presenting the peptide in a conformationally restricted form; use in screening peptide libraries |
06/14/2001 | US20010003585 Introducing a viral expression vector having a tumoricidal or susceptibility gene into a mammalian cell and attaching the cell to a support matrix in vitro; transferring the supported cells to mammalian tumor cells; durability; brains |
06/14/2001 | CA2395378A1 Dna molecules encoding human nhl, a dna helicase |
06/14/2001 | CA2394917A1 Polypeptides and polynucleotides encoding same |
06/14/2001 | CA2394303A1 Interferon-alpha induced gene |
06/14/2001 | CA2393960A1 Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions |
06/14/2001 | CA2393859A1 Apoptin-associating protein |
06/14/2001 | CA2393738A1 Inducing cellular immune responses to her2/neu using peptide and nucleic acid compositions |
06/14/2001 | CA2393725A1 Histone deacetylase-8 proteins, nucleic acids, and methods of use |
06/14/2001 | CA2393661A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
06/14/2001 | CA2393589A1 Compositions and methods for detecting stress-inducible proteins |
06/14/2001 | CA2393562A1 Detection of transmembrane potentials by optical methods |
06/14/2001 | CA2393532A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
06/14/2001 | CA2393463A1 Contortrostatin (cn) and methods for its use in preventing metastasis and other conditions |
06/14/2001 | CA2393454A1 Infection of eukaryotic cells with viruses in vitro |
06/14/2001 | CA2393071A1 Long-term cell culture compositions and genetically modified animals derived therefrom |
06/14/2001 | CA2393045A1 Mutant er.alpha. and test systems for transactivation |
06/14/2001 | CA2392961A1 G-protein coupled receptors |
06/14/2001 | CA2392764A1 Inducing cellular immune responses to carcinoembryonic antigen using peptide and nucleic acid compositions |
06/14/2001 | CA2392753A1 Use of multiple recombination sites with unique specificity in recombinational cloning |
06/14/2001 | CA2392742A1 T1 receptor-like ligand ii and uses thereof |
06/14/2001 | CA2392740A1 Il-6 like polynucleotides, polypeptides, and antibodies |
06/14/2001 | CA2392299A1 Methods for expression of genes in primates |
06/14/2001 | CA2383001A1 Methods for introducing genes into mammalian subjects |
06/14/2001 | CA2382165A1 Full-length human cdnas encoding potentially secreted proteins |
06/14/2001 | CA2361563A1 Use of polyacrylamide gel for forming a connective-tissue capsule in a mammal for cultivating allogenic or xenogenic cells |
06/13/2001 | EP1107003A1 Methods for screening compounds active on neurons |
06/13/2001 | EP1106696A1 Protein-deamidating enzyme, microorganism producing the same, gene encoding the same, production process therefor, and use thereof |
06/13/2001 | EP1106692A1 Rna virus vector having contact infiltration capability |
06/13/2001 | EP1106690A2 Polynucleotide encoding autoantigens associated with endometriosis |
06/13/2001 | EP1106689A2 Nucleic acids encoding acetylcholine beta subunits from insects |
06/13/2001 | EP1106620A2 Method for obtaining components from cultured leucocytes |
06/13/2001 | EP1106183A2 Antibodies to erbB2 and their therapeutic uses |
06/13/2001 | EP1106065A2 Method of and container for storing and transporting vital tissue, fluid or cell materials |
06/13/2001 | EP1105732A1 Agarose format for mammalian cell based reporter assays |
06/13/2001 | EP1105538A2 HUMAN STEAROYL-CoA DESATURASE-RELATED COMPOSITIONS AND METHODS FOR TREATING SKIN DISORDERS |
06/13/2001 | EP1105526A1 Hepg2 cells stably transfected with hcv |
06/13/2001 | EP1105522A1 Enzyme activity screen with direct substrate reloading |
06/13/2001 | EP1105511A1 Transgenic plants and plant cells comprising a reduced expression of invertase inhibitors |
06/13/2001 | EP1105510A2 Dna shuffling to produce herbicide selective crops |
06/13/2001 | EP1105508A1 Method for purifying proteins and biomolecule or protein complexes |
06/13/2001 | EP1105507A1 Overexpression of desired proteins in eukaryotic cells mediated by cyclin d1 overexpression |
06/13/2001 | EP1105504A1 Cyclophilin-type peptidyl-prolyl cis/trans isomerase |
06/13/2001 | EP1105502A2 Maize cellulose synthases and uses thereof |
06/13/2001 | EP1105501A2 Tpl-2/cot kinase and methods of use |
06/13/2001 | EP1105488A2 $i(CHLAMYDIA) ANTIGENS AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF |
06/13/2001 | EP1105486A2 Genes for plant fatty acid modifying enzymes associated with conjugated double bond formation |
06/13/2001 | EP1105485A1 Human il-1 epsilon dna and polypeptides |
06/13/2001 | EP1105483A1 Genes involved in the molecular paths for tumour suppression and /or resistance to viruses |
06/13/2001 | EP1105481A2 Peripheral-type benzodiazepine receptor associated proteins, cloning, expression and methods of use |
06/13/2001 | EP1105480A1 14274 receptor, a g-protein coupled receptor related to the edg receptor family |
06/13/2001 | EP1105479A2 Identification of the gene causing the mouse scurfy phenotype and its human ortholog |
06/13/2001 | EP1105478A1 Extracellular adhesive proteins, exadh1 and exadh2 |
06/13/2001 | EP1105477A1 Dcr5, a bmp-binding protein, and applications thereof |
06/13/2001 | EP1105475A1 Tissue factor protein variants with increased affinity for coagulation factor fvii/fviia |
06/13/2001 | EP1105474A2 Human genes and gene expression products v |
06/13/2001 | EP1105473A2 A single gene encoding aortic-specific and striated-specific muscle cell isoforms, its regulatory sequences and uses thereof |
06/13/2001 | EP1105470A1 USE OF SUPPRESSOR tRNA'S TO REGULATE CYTOTOXICITY DURING THE PRODUCTION OF RECOMBINANT GENE PRODUCTS |
06/13/2001 | EP1105469A1 Mammalian transgenesis by intracytoplasmic sperm injection |
06/13/2001 | EP1105468A2 A NOVEL PLASTID-TARGETING NUCLEIC ACID SEQUENCE, A NOVEL $g(b)-AMYLASE SEQUENCE, A STIMULUS-RESPONSIVE PROMOTER AND USES THEREOF |
06/13/2001 | EP1105465A1 NOVEL G PROTEIN-COUPLED RECEPTOR cDNA SEQUENCE |
06/13/2001 | EP1105464A1 Human mesencephalon cell lines and methods of use therefor |
06/13/2001 | EP1105463A1 Cell population containing non-fetal hemangioblasts and method for producing same |
06/13/2001 | EP1105462A1 Engraftable human neural stem cells |
06/13/2001 | EP1105460A2 Differentiation of non-insulin producing cells into insulin producing cells by glp-1 or exendin-4 and uses thereof |
06/13/2001 | EP1105459A1 Transgenic nonhuman mammal and uses thereof to identify compounds useful for improving long-term memory |
06/13/2001 | EP1105425A1 Monoclonal antibodies specific for streptococcus mutans, and uses thereof |
06/13/2001 | EP1105418A1 Vanadate resistance glycosylation 4 gene |
06/13/2001 | EP1105411A1 nrdE |
06/13/2001 | EP1105408A1 Congugates of dna interacting groups with steroid hormones for use as nucleic acid transfection agents |
06/13/2001 | EP1105406A1 Novel esk potassium channel polypeptide and polynucleotide compositions |
06/13/2001 | EP1105405A2 Gene regulating circadian clock function and photoperiodism |
06/13/2001 | EP1105157A1 Protein delivery system using human papillomavirus virus-like particles |